Bases bibliographiques Pascal et Francis

Aide

Résultats de votre recherche

Votre recherche

kw.\*:("CHOP regimen")

Année de publication [py]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Discipline (document) [di]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Pays auteur

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Résultats 1 à 25 sur 61

  • Page / 3
Export

Sélection :

  • et

Anthracycline-based chemotherapy as primary treatment for intravascular lymphomaFERRERI, A. J. M; CAMPO, E; ERIKSSON, M et al.Annals of oncology. 2004, Vol 15, Num 8, pp 1215-1221, issn 0923-7534, 7 p.Article

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphomaTILLY, Hervé; LEPAGE, Eric; GISSELBRECHT, Christian et al.Blood. 2003, Vol 102, Num 13, pp 4284-4289, issn 0006-4971, 6 p.Article

ACVBP versus CHOP plus radiotherapy for localized aggressive lymphomaREYES, Félix; LEPAGE, Eric; LAURENT, Guy et al.The New England journal of medicine. 2005, Vol 352, Num 12, pp 1197-1205, issn 0028-4793, 9 p.Article

FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphomaDONG HWAN KIM; HEE DU JUNG; SANG KYUN SOHN et al.Blood. 2006, Vol 108, Num 8, pp 2720-2725, issn 0006-4971, 6 p.Article

Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years oldITALIANO, Antoine; JARDIN, Fabrics; PEYRADE, Frederic et al.Haematologica (Roma). 2005, Vol 90, Num 9, pp 1281-1283, issn 0390-6078, 3 p.Article

Abnormal expression of cell cycle regulators in FUS-CHOP carrying liposarcomasOLOFSSON, Anita; WILLEN, Helena; GÖRANSSON, Melker et al.International journal of oncology. 2004, Vol 25, Num 5, pp 1349-1355, issn 1019-6439, 7 p.Article

CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients : A study by the groupe d'etude des lymphomes de l'adulteBONNET, Christophe; FILLET, Georges; TILLY, Hervé et al.Journal of clinical oncology. 2007, Vol 25, Num 7, pp 787-792, issn 0732-183X, 6 p.Article

Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-hodgkin lymphomaBURTON, C; SMITH, P; VAUGHAN-HUDSON, G et al.British journal of haematology. 2005, Vol 130, Num 4, pp 536-541, issn 0007-1048, 6 p.Article

High expression of cyclin B 1 predicts a favorable outcome in patients with follicular lymphomaBJÖRCK, Erik; EK, Sara; LANDGREN, Ola et al.Blood. 2005, Vol 105, Num 7, pp 2908-2915, issn 0006-4971, 8 p.Article

The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapyNAVARRO, José-Tomas; LLOVERAS, Natalia; RIBERA, Josep-Maria et al.Haematologica (Roma). 2005, Vol 90, Num 5, pp 704-706, issn 0390-6078, 3 p.Article

Gene expression profile identifies a rare epithelioid variant case of pleomorphic liposarcoma carrying FUS-CHOP transcriptDE CECCO, L; GARIBOLDI, M; REID, J. F et al.Histopathology. 2005, Vol 46, Num 3, pp 334-341, issn 0309-0167, 8 p.Article

Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy : results of a GOELAMS studyBERNARD, Marc; CARTRON, Guillaume; CASSASUS, Philippe et al.Haematologica (Roma). 2005, Vol 90, Num 6, pp 802-809, issn 0390-6078, 8 p.Article

Phase I study of rituximab-CHOP regimen in combination with granulocyte colony-stimulating factor in patients with follicular lymphomaNIITSU, Nozomi; HAYAMA, Miyuki; OKAMOTO, Masataka et al.Clinical cancer research. 2004, Vol 10, Num 12, pp 4077-4082, issn 1078-0432, 6 p., 1Article

Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-BTODESCHINI, G; SECCHI, S; GABBAS, A et al.British journal of cancer. 2004, Vol 90, Num 2, pp 372-376, issn 0007-0920, 5 p.Article

Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's Lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-upCZUCZMAN, Myron S; WEAVER, Robin; ALKUZWENY, Baha et al.Journal of clinical oncology. 2004, Vol 22, Num 23, pp 4659-4664, issn 0732-183X, 6 p.Article

Current trends in large cell lymphomaFISHER, R. I; SHAH, P.Leukemia. 2003, Vol 17, Num 10, pp 1948-1960, issn 0887-6924, 13 p.Article

CD64 surface expression on neutrophils and monocytes is significantly up-regulated after stimulation with granulocyte colony-stimulating factor during CHOP chemotherapy for patients with non-Hodgkin's lymphomaKAKINOKI, Yasutaka; KUBOTA, Hiroya; YAMAMOTO, Yasushi et al.International journal of hematology. 2004, Vol 79, Num 1, pp 55-62, issn 0925-5710, 8 p.Article

Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphomaZINZANI, Pier Luigi; PULSONI, Alessandro; TUCCI, Alessandra et al.Journal of clinical oncology. 2004, Vol 22, Num 13, pp 2654-2661, issn 0732-183X, 8 p.Article

Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma : a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)VERDONCK, Leo F; NOTENBOOM, Annelise; DE JONG, Daphne D et al.Blood. 2007, Vol 109, Num 7, pp 2759-2766, issn 0006-4971, 8 p.Article

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOPSEHN, Laurie H; BERRY, Brian; GASCOYNE, Randy D et al.Blood. 2007, Vol 109, Num 5, pp 1857-1861, issn 0006-4971, 5 p.Article

Prospective randomized study comparing MEMID with a CHOP-like regimen in elderly patients with aggressive non-Hodgkin's lymphomaCHAMOREY, E; GRESSIN, R; MAISONNEUVE, H et al.Oncology. 2005, Vol 69, Num 1, pp 19-26, issn 0030-2414, 8 p.Article

Economic evaluation of prophylactic granulocyte colony-stimulating factor during chemotherapy in elderly patients with aggressive non-Hodgkin's lymphomaDOORDUIJN, Jeanette K; BUIJT, Ivon; VAN DER HOLT, Bronno et al.Haematologica (Roma). 2004, Vol 89, Num 9, pp 1109-1117, issn 0390-6078, 9 p.Article

Differential diagnosis and treatment of primary, cutaneous, anaplastic large cell lymphoma: not always an easy taskDIAMANTIDIS, Michael D; PAPADOPOULOS, Athanasios; SAVOPOULOS, Christos et al.International journal of hematology. 2009, Vol 90, Num 2, pp 226-229, issn 0925-5710, 4 p.Article

Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma : a phase II study of feasibility and toxicityBRUSAMOLINO, Ercole; RUSCONI, Chiara; MORRA, Enrica et al.Haematologica (Roma). 2006, Vol 91, Num 4, pp 496-502, issn 0390-6078, 7 p.Article

Prognostic significance of Bcl-6 protein expression in DLBCL treated with chop or R-CHOP : a prospective correlative study. CommentaryMOSKOWITZ, Craig; WINTER, Jane N; CHHANABHAI, Mukesh et al.Blood. 2006, Vol 107, Num 11, issn 0006-4971, 4197-4198,4207-4213 [9 p.]Article

  • Page / 3